baber/WOPTO huggingface dataset:
Patent NZ-332029-A (NZ)
Title: Sulfonamide substituted chromans, process for their preparation, their use as a medicament and pharmaceutical preparations comprising them
Inventor: BRENDEL JOACHIM
IPC: C07D405/12
Filed: 1998-09-24
Abstract: The compound of formula I blocks the potassium channel opened by cAMP and the IsK channel. R1 and R2 are independently H, CF3, C2F5, C3F7, alkyl with 1-6 carbons, or a substituted or unsubstituted phenyl; or R1 and R2 together are an alkylene chain with 2-10 carbon atoms. R3 is R(10)-Cn-H2n-NR(11) or R(10)-CnH2n-, (wherein R(10) is H, methyl, cycloalkyl with 3-8 carbons, CF3, C2F5 or C3F7; R(11) is H or an alkyl with 1-6 carbon atoms; and one CH2 in Cn-H2n can be replaced by -O-, -CO- or other group). R4 is R(13)-CrH2r-Z-CqH2q-, wherein R(13) is H, CF3, C2F5, C3F7, a cycloalkyl with 3-8 carbon atoms or other group; and Z is -O-CxH2x-O-, -O-CxH2x-CO-O- or other group). R5, R6, R7 and R8 are independently H, F, Cl, Br, I, alkyl with 1-5 carbon atoms, cycloalkyl with 3-8 carbons, CN , phenyl or other group. R9 is H, OR(10d) or OCOR(10d), wherein R(10d)  is H or alkyl having 1-3 carbons. B is hydrogen, or together with R9 is a bond. The compound or a physiologically tolerable salt thereof is used in a medicament for therapy of cardiovascular disorders, the treatment of ulcers of the gastrointestinal area or the treatment of diarrheal disorders.
Patent NZ-332457-A (NZ)
Title: A die for manufacturing soap bars where the cooling fluid is vapourised in the die
Inventor: HUTCHERSON ALLAN BRUCE
IPC: C11D13/12
Filed: 1997-04-03
Abstract: A method of manufacture soap bars is claimed comprising a)	providing a first die member and a second dye member which co-operates with the first die member to provide a dye cavity; b)	locating the die members so that they are spaced by a gap; c)	delivering the gap a block of material from which the soap bar is to be formed d)	bringing the die members together so that the material is enclosed in the cavity formed by the die members; e)	circulating a cooling fluid through the die members to cool the material; the cooling fluid passes from a liquid phase to a gaseous phase within the die members; f)	separating the die members to expose the formed soap bar and g)	ejecting the soap bar from between the die members.
Patent NZ-335252-A (NZ)
Title: Substituted 3-thia-1,2,3,4-tetrahydrocarbazole, 6,7,8,9-tetrahydropyrido[1,2-a]indole, 4,5-dihydro-thiopyrano[3,4-b]indole, pyrano[3,4-b]indole or beta-carbolinyl derivatives
Inventor: BACH NICHOLAS JAMES
IPC: C07D513/04
Filed: 1999-04-16
Abstract: The indole derivatives or pharmaceutically acceptable salts thereof have the formula I wherein: A is phenyl or pyridyl; one of B or D is nitrogen and the other is carbon; Z is cyclohexyl, phenyl, pyridyl or a 6 membered heterocyclic ring having a heteroatom chosen from S, N or O; The dashed line is either a single or double bond; R20 is optionally substituted alkyl, alkenyl, alkynyl, carbocyclic or heterocyclic radical or is -(L)-R80; L is a divalent linking group of 1 to 12 atoms selected from carbon, hydrogen, oxygen, nitrogen and sulphur; R80 is optionally substituted alkyl, alkenyl, alkynyl, carbocyclic or heterocyclic radical; R21 is a non-interfering substituent; R1' is NHNH2, NH2 or CONH2; R2' is OH or O(CH2)-R5'; R3' is a non-interfering substituent, optionally substituted carboyclic radical or heterocyclic radicals and R5' is as defined in the specification provided that one of A or Z is a heterocyclic ring and when D is nitrogen, the heteroatom of Z is S or O in positions 1, 2 or 3 or N in positions 1, 2, 3 or 4. A pharmaceutical composition thereof is useful in treating sepsis, septic shock, rheumatoid arthritis, stroke, asthma, or pancreatitis.
Patent NZ-335301-A (NZ)
Title: Aqueous mycobacterial composition and hard surface disinfecting composition
Inventor: MCCUE KAREN A
IPC: A01N33/12
Filed: 1997-09-10
Abstract: Disclosed are aqueous mycobacterial concentrate compositions at a pH in the range of 6 to 12 which comprises per 100% weight of a concentrate composition: a)	from about 0.1% wt. to about 25% wt. of a germicidal cationic quaternary ammonium compound; b)	from about 0.25% wt. to about 25% wt. of a solvent selected from: phenoxyalcohol, glycol ethers, or mixtures thereof; and, c)	water. The concentrate compositions may be used in a ready to use form, or may be further diluted with water to form a disinfecting composition. The compositions may also include an effective amount of a pH adjusting agent, such as sodium hydroxide or triethanolamine. The compositions feature reduced amounts of active constituents when compared with those known to the art.  They are particularly effective against Mycobacteriuin terrae.   Also disclosed is a method of disinfecting a hard surface.
Patent NZ-500719-A (NZ)
Title: Predistorting network for external optical modulator
Inventor: GOBETTI GIANLUCA
IPC: H04B10/50
Filed: 1998-05-08
Abstract: A method and a signal predistorter circuit 33 is disclosed for eliminating the nonlinearities in the input/output characteristics of nonlinear stages, in particular for eliminating the third-order nonlinearities for external optical modulators of television signals. The method for predistortion of a signal of variable amplitude includes delivering the said signal to at least one first distorter circuit 33 which is biased to a prefixed working point Vp and distorting the said signal in the first distorter circuit. Biasing of the first distorter circuit includes providing a path D7, D8 in parallel to the distorter circuit to maintain a substantially constant bias voltage so that the prefixed working point does not vary as the amplitude of the input signal to the distorter varies.
Patent NZ-501844-A (NZ)
Title: Alkanoyl L-carnitine in combination with a statin (simvastatin, lovastatin, provastatin or fluvastatin) for treating abnormal lipid metabolism disorders
Inventor: CAVAZZA CLAUDIO
IPC: A61K31/365
Filed: 1998-06-18
Abstract: A synergistic orally and parenterally administrable pharmaceutical composition comprising an alkanoyl L-carnitine and a statin; wherein the alkanoyl group comprises of linear or branched C2-6alkanoyl. The composition is suitable for treating cardiovascular diseases caused by abnormal lipid metabolism.
Patent NZ-503659-A (NZ)
Title: Winding cable-like winding on or off inductor core to vary reactance
Inventor: BERGGREN SOREN
IPC: H01F27/32
Filed: 1998-09-29
Abstract: A transformer or reactor magnetic core 1 is wound with an insulating electric conductor 2 including at least one current carrying conductor, a first layer having semiconducting properties arranged to surround the conductor, a solid insulation layer arranged to surround said first layer, and a second layer having semiconducting properties arranged to surround the insulating layer. A regulating winding 3 is arranged around a magnetic flux carrier core 1, and the conductor of the regulating winding can be wound on or off the core from winding drum 12 to vary the length of said regulating winding around the magnetic flux core and thereby regulate the induced voltage in the transformer or the reactive power of the reactor.
Patent NZ-510202-A (NZ)
Title: Maize cellulose synthases for use in producing transgenic corn plants that are less susceptible to brittle corn snap by altering the cellulose content in the cell wall
Inventor: DHUGGA KANWARPAL S
IPC: C12N15/29
Filed: 1999-08-16
Abstract: An isolated nucleic acid comprises a member selected from: (a) a polynucleotide having at least 80% sequence identity, as determined by the BLAST 2.0 algorithm under the default parameters to a polynucleotide encoding a polypeptide selected from the group consisting of SEQ ID NO: 2, 6, 10, 14, 18, 26 and 58; (b) A polynucleotide encoding a polypeptide of SEQ ID NO: 2, 6,10, 14, 18, 26 and 58; (c) A polynucleotide amplified from a Zea mays nucleic acid library using primers which selectively hybridize, under stringent hybridization conditions to loci within a polynucleotide selected from the group consisting of 1, 5, 9, 13, 17, 25, and 57; (d) A polynucleotide which selectively hybridizes, under stringent hybridization conditions and a wash in 2X SSC at 50oC, to a polynucleotide of 1, 5, 9, 13, 17, 25, and 57. (e) A polynucleotide of SEQ ID NO: 1, 5, 9, 13, 17, 25, and 57; (f) A polynucleotide which is complementary to a polynucleotide of (a), (b), (c), (d) and (e); and (g) A polynucleotide comprising at least 25 contiguous nucleotides from a polynucleotide of (a), (b), (c), (d), (e) or (f) and having at least east 80% sequence identity, as determined by the BLAST 2.0 algorithm under the default parameters to the polynucleotide it is selected from. Also described are proteins comprising a member selected from: a polypeptide of at least 20 contiguous amino acids from a polypeptide of SEQ ID NO: 2, 6, 10, 14, 18, 26 and 58 and having at least east 80% sequence identity, as determined by the BLAST 2.0 algorithm under the default parameters to the polypeptide that it is selected from, polypeptide of SEQ ID NO: 2, 6, 10, 14, 18, 26 and 58, a polypeptide having at least 80% sequence identity to, and having at least one linear epitope in common with, a polypeptide of SEQ ID NO: 2, 6, 10, 14, 18, 26, wherein the sequence identity is determined by the BLAST 2.0 under the default parameters and a polypeptide encoded by a polynucleotide as described above. Non-human host cell and transgenic plants comprising recombinant expression cassettes comprising the polynucleotide and methods of modulating the level of cellulose synthase in a plant cell are described.
Patent NZ-510855-A (NZ)
Title: Derivatives of isosorbid mononitrate and its use as vasodilating agents with reduced tolerance
Inventor: NEGRIE ROFES CRISTINA
IPC: C07D493/04
Filed: 1999-10-04
Abstract: Disclosed are derivatives of isosorbid mononitrate and pharmaceutically acceptable salts thereof which have a vasodilator activity with a reduced tolerance effect, having the general formula (I) wherein A and B represent independently any of the groups NO2 and-CO-R, Z being an atom of oxygen or sulfur, and R being optionally substituted C1-C4 alkyl, aryl or aralkyl group or the group (a) wherein R1 is hydrogen or optionally substituted C1-C4 alkyl, aryl or aralkyl group,so that always either A or B is NO2 but never both at the same time, when Z is a sulfur atom R is optionally substituted C1-C4 alkyl, aryl or aralkyl group, and when Z is an oxygen atom R is the group (a).
Patent NZ-512596-A (NZ)
Title: Cell line expressing non-native cell surface receptors
IPC: C12N5/10
Filed: 1998-05-28
Abstract: A trimer is described, comprising three monomers, each having an amino terminus of an adenoviral fibre protein and each having a trimerization domain.  The trimer exhibits reduced affinity for a native substrate when compared with a native adenoviral fibre trimer.  An adenovirus incorporating the trimer is also provided.
Patent NZ-513787-A (NZ)
Title: Improved restraining device
Inventor: FULLER ROGER STEPHEN
IPC: E05B75/00
Filed: 2000-02-04
Abstract: A restraining device comprising a support (2) incorporating a handle (3) and spaced apart first and second anchor points (4, 5, 10, 17), a strap (6) being attached to the first anchor point (4, 10) and slidably attached to the second anchor point (5, 17), the strap (6) and the support (2) defining a restraining enclosure (15) to enclose a detainee, wherein in use, movement of the strap (6) in a forward direction reduces the area of the enclosure (15) and movement of the strap (6) in a reverse direction increases the area of the enclosure (15).
Patent NZ-515366-A (NZ)
Title: Method for producing vicinal diols of compounds (especially lanosterol and cyclohexane derivatives) by reacting compounds with acids with pKa of less than or equal to 2 in the presence of one or more reagents capable of supplying hydroxy groups
Inventor: KAVTARADZE LEVAN KITA
IPC: C07C29/10
Filed: 2001-11-08
Abstract: The application discloses a method of producing vicinol diols from a compound. The method is characterized by the step of reacting the compound with moderately strong acid in the presence of one or more reagents capable of supplying hydroxyl groups. Specifically described is a method of producing lanosterol or an intermediate thereof. In order to remove impurities from the lanosterol the application describes a method of forming a lanosterol intermediate then separating the intermediate from the impurities and finally converting the intermediate into lanosterol.
Patent NZ-516549-A (NZ)
Title: Method and device for pyrolyzing and gasifying organic substances or substance mixtures
Inventor: KRUMM WOLFGANG
IPC: C10B49/16
Filed: 2000-06-27
Abstract: A method for pyrolysing and gasifying organic substances or organic substance mixtures. The organic substances are introduced into a drying and pyrolysis reactor in which they are brought into contact with the fluidised-bed material of the combustion fluidised bed or in which they are brought into contact with the fluidised-bed material and the reactor wall of the combustion fluidised bed, whereby a drying and a pyrolysis occurs.  The fluidised-bed material and the solid residue which contains carbon are fed, optionally with portions of the water vapour and of the pyrolysis gases, back into the combustion fluidised bed in which the residue of the organic substances which contains carbon is combusted, the fluidised-bed material is heated and is fed once again into the pyrolysis reactor. The water vapour resulting from the drying, and the pyrolysis gases are subsequently treated with condensable substances in another reaction zone so that a product gas having a high thermal value is produced. The drying and the pyrolysis are carried out in at least one or more pyrolysis reactors.  The combustion fluidised bed in which the pyrolysis residues are combusted is operated as a stationary fluidised bed.  The pyrolysis gases are led into an indirect heat exchanger.  The firing waste gases are, optionally with the fluidised-bed material of the combustion fluidised bed, brought into contact with the indirect heat exchanger in such a manner that the heat content thereof is used for reacting the pyrolysis gases with the reaction agent.
Patent NZ-518451-A (NZ)
Title: A hydronaphtalene ring compound, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
Inventor: FAGNOU KEITH
IPC: C07C219/00
Filed: 2000-10-26
Abstract: A process for making an enantiomerically enriched compound containing a hydronaphthalene ring structure is disclosed, wherein the process involves reacting oxabenzonorbornadienes with nucleophiles using rhodium as a catalyst and in the presence of a phosphine ligand. The compounds synthesized may be used in pharmaceutical preparations for the treatment of a variety of diseases and conditions such as Parkinson's disease and cancer.
Patent NZ-520884-A (NZ)
Title: Apoptosis-inducing compounds
Inventor: WILLIAMS DAVID CLIVE
IPC: C07D498/04
Filed: 2001-02-09
Abstract: A pharmaceutical composition comprising an apoptosis-inducing amount of a compound having the general formula (I) for the treatment of tumours or other cancerous conditions, where: - R1 represents a 1-naphthyl group; - A represents O, S or S partially oxidized to sulfoxide; - The cyclic group labeled F represents an unsubstituted C6 or C10 aryl-fused group or a C5 heteroaryl-fused group (nitrogen as heteroatom) or a benzo-fused substituted with ethoxycarbonyl function; - Y presents the group of formula (II), where R2 and R3 are independently hydrogen or methyl. Alternatively, Y represents the group CH3 or a (CH2)2CH3 group; or an unsubstituted C5 heteroaryl group (nitrogen as heteroatom).
Patent NZ-521776-A (NZ)
Title: Charge system for use of two-dimensional code
Inventor: WAKAMOTO MASAKI
IPC: G06Q30/04
Filed: 2000-07-03
Abstract: This charge system is for charging for the use of image information or a two dimensional code in electronic commerce involving sending and receiving information regarding advertising, presentation or sale of merchandise over a public communication line. The system charges a certain fee to a party originating commercial information, based on the number of times that a user of the information or code has scanned with a scanning device the image information or two dimensional code attached to a medium, such as a piece of paper or merchandise, which has been furnished by the party originating the commercial information, wherein: for the image information the originating party originates commercial information, attaches certain image information into which necessary information and authentication data has been entered onto a medium and furnishes the medium to a consumer or for the two-dimensional code the originating party creating a two-dimensional code originates commercial information attaches certain two-dimensional code into which necessary information and a serial number has been entered onto a medium and furnishes the medium to a consumer to verify the originating party, the consumer confirms the identity of the party originating the commercial information when accessing the commercial information by specifying the originating party based on the scanned authentication data of the image information or serial number of the two-dimensional code on the medium; and based on the authentication data and the number of hits thereof, the party originating the commercial information is charged for the use of the image information or the two-dimensional code.
Patent NZ-523220-A (NZ)
Title: Transgenically produced platelet derived growth factor
Inventor: ECHELARD YANN
IPC: C07K14/49
Filed: 2001-06-19
Abstract: Transgenically produced glycosylated platelet derived growth factor (PDGF), e.g., transgenically produced PDGF which is expressed in the milk of a transgenic mammal, and is present in the milk in active form, e.g., as a dimmer is disclosed. Also disclosed are methods of producing transgenic PDGF, transgenic animals capable of expressing PDGF, and nucleic acid sequences encoding PDGF, e.g., nucleic acid sequences encoding PDGF, under the control of a mammary gland specific promoter.
Patent NZ-524460-A (NZ)
Title: Digital media quality adjustment by changing streaming constraints e.g. improving bandwidth by not sending audio upon user request
Inventor: PAWSON DAVID J
IPC: H04N7/173
Filed: 2001-08-30
Abstract: A method and apparatus for dynamic quality adjustment of digital media based on changing streaming constraints is provided. A digital media server sends a digital media stream according to a set of streaming constraints to a requesting client. A client sends a request (400) over a control network to the digital media server indicating information of a particular type is no longer desired. In response to receiving the signal, the video server ceases transmission of that particular type of information (430) to the signaling client, thus relaxing streaming constraints (440). when a viewer signals that a particular type of information is not desired, that particular type of information is not transmitted to the client, which thereby reduces the streaming constraints on a video streaming service, and improved quality digital media information (450) may be sent to any client using the freed-up portion of the bandwidth previously allocated to the signaling client.
Patent NZ-525027-A (NZ)
Title: Apparatus and method for wastewater treatment with enhanced solids reduction (ESR)
Inventor: GARCIA PAUL G
IPC: C02F1/00
Filed: 2001-10-05
Abstract: A wastewater treatment process that provides improved reduction of total solids through endogenous respiration while reducing biochemical oxygen demand and utilizing biological nutrient reduction is disclosed, wherein the wastewater treatment process uses an efficient aeration delivery system to drastically reduce the time needed to oxidize organic matter, and re-circulates, shreds and homogenizes the organic matter and microorganisms and oxygenates the entire mass many more times than traditional systems resulting in a greater biological solids digestion rate.
Patent NZ-527726-A (NZ)
Title: Recombinant high molecular weight major outer membrane protein of moraxella
Inventor: LOOSMORE SHEENA M
IPC: C12N15/31
Filed: 2000-07-26
Abstract: An isolated and purified nucleic acid molecule has a nucleotide sequence selected from that set forth in Figure 5 (SEQ ID NO:10) for Moraxella catarrhalis strain LES-1 or the sequence encoding an about 200 kDa outer membrane protein strain for Moraxella catarrhalis strain LES-1. Vectors, cells, proteins and methods of producing the protein are also described. An immunogenic composition can comprise the protein for use as a vaccine to protect against disease caused by Moraxella catarrhalis.
Patent NZ-531268-A (NZ)
Title: Vacuum assisted tissue treatment system
Inventor: BOYNTON THOMAS A
IPC: A61M27/00
Filed: 2002-08-23
Abstract: A system (10) for stimulating the healing of tissue comprises a porous pad (11) positioned within a wound cavity (12), and an airtight dressing (13) secured over the pad, so as to provide an airtight seal to the wound cavity. A proximal end (16a) of a conduit (16) is connectable to the dressing. A distal end (16b) of the conduit is connectable to a negative pressure source (14), which may be an electric pump housed within a portable housing (32), or wall suction. A canister (18) is positioned along the conduit to retain exudates suctioned from the wound site during the application of negative pressure. A first hydrophobic filter (20) is positioned at an opening of the canister to detect a canister full condition. A second hydrophobic filter (22) is positioned between the first filter and the negative pressure source to prevent contamination of the non-disposable portion of the system by exudates being drawn from the wound. An odour filter (23) is positioned between the first and second hydrophobic filters to aid in the reduction of malodorous vapours. A securing means (34) is supplied to allow the portable housing to be secured to a stationary object, such as a bed rail or intravenous fluid support pole. A means for automated oscillation of pressure over time is provided to further enhance and stimulate the healing of an open wound. A means for varying pump drive frequency and a means for managing a portable power supply are provided to increase battery life and improve patient mobility.
Patent NZ-533438-A (NZ)
Title: Apparatus and method for manufacturing bread
Inventor: HAYASHI TORAHIKO
IPC: A21C3/06
Filed: 2003-04-25
Abstract: Starting materials for bread are kneaded and the bread dough thus obtained is shaped into a sheet. Then the bread dough sheet is rolled up or folded to give a bar-type bread dough. After cutting, the bread dough slices are put into a mold with the cut surface upward. Thus, bubbles remaining in the overlaps of the bread dough migrate in the overlaps and get scattered from the cut surface in the course of the fermentation or rising by baking.
Patent NZ-536068-A (NZ)
Title: Quinolinone derivatives
Inventor: RENHOWE PAUL A
IPC: A61P9/00
Filed: 2003-04-04
Abstract: Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treatin along with an anti-cancer drug selected from 5-FU or CPT-11. The medicaments may be used in treating cancer. The use of a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treating cancer in conjunction with an anti-cancer drug selected from 5-FU or CPT-11 is also provided.